Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Skyhawk Therapeutics

Skyhawk Therapeutics

Skyhawk Therapeutics is a RNA-correcting Small Molecules founded in 2016 by Bill Haney.

OverviewStructured DataIssuesContributorsActivity
Is a
Company
Company
Organization
Organization
B2X
B2B
B2B
0
CEO
Bill Haney
Bill Haney
0
Company Operating Status
Active
Country
United States
United States
0
Switzerland
Switzerland
0
Crunchbase URL
crunchbase.com/organiz...apeutics
Email Address
info@skyhawktx.com
0
swiss-info@skyhawktx.com
0
Founded Date
2016
Founder
‌
Kathleen McCarthy
0
Bill Haney
Bill Haney
0
Full Address
Hochbergerstrasse 60C Basel 4057 Switzerland
0
35 Gatehouse Dr, Waltham, Massachusetts 02451, US
0
Industry
Biomedical engineering
Biomedical engineering
Biopharmaceutical
Biopharmaceutical
Technology
Technology
Cancer
Cancer
Oncology
Oncology
RNA-based and RNA-targeted therapeutics
RNA-based and RNA-targeted therapeutics
Parkinson's disease
Parkinson's disease
Biology
Biology
Biotechnology
Biotechnology
Internal medicine
Internal medicine
•••
Investors
Shangbay Capital
Shangbay Capital
Good Growth Capital
Good Growth Capital
0
Agent Capital
Agent Capital
Latest Funding Round Date
June 26, 2018
Latest Funding Type
Seed
Seed
LinkedIn URL
@company/skyhawk-therapeutics
Location
United States
United States
Basel
Basel
0
Waltham, Massachusetts
Waltham, Massachusetts
0
Number of Employees (Ranges)
51 – 200
0
Patents Assigned (Count)
5
Phone Number
+16178580041
0
+41616382350
0
Pitchbook URL
pitchbook.com/profiles...224321-05
Total Funding Amount (USD)
48,000,000
Twitter URL
@Skyhawk_Tx
Official Website
skyhawktx.com

Find more companies like Skyhawk Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo